
Catalent is a drug manufacturers - specialty & generic company in the healthcare sector on NYSE, led by Alessandro Maselli, with a market cap of $11.5B. As of Q3 2025, 0% of shares are held by 1 institutional investors, with HUNTINGTON NATIONAL BANK as the largest holder at -.
Overview of institutional ownership in CTLT as of Q3 2025 with a market cap of $11.5B
Based on market cap of $11.5B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in CTLT as of Q3 2025
| Institution | Position Value |
|---|---|
H HUNTINGTON NATIONAL BANK Long Only Manager | $63.0 0.00% of portfolio |
Institutional buying and selling activity for CTLT in Q3 2025
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited CTLT in Q3 2025
| Institution | Position Value |
|---|---|
| No new positions found | |
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Institutions with the largest Call and Put options positions in CTLT as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with CTLT as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
H HUNTINGTON NATIONAL BANK Long Only Manager | 0.00% $63.0 |
We use cookies for analytics. See our Privacy and Cookie Policy.